• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿呼吸系统疾病的基因检测

Genetic Testing for Neonatal Respiratory Disease.

作者信息

Nogee Lawrence M, Ryan Rita M

机构信息

Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Division of Neonatology, Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

Children (Basel). 2021 Mar 11;8(3):216. doi: 10.3390/children8030216.

DOI:10.3390/children8030216
PMID:33799761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8001923/
Abstract

Genetic mechanisms are now recognized as rare causes of neonatal lung disease. Genes potentially responsible for neonatal lung disease include those encoding proteins important in surfactant function and metabolism, transcription factors important in lung development, proteins involved in ciliary assembly and function, and various other structural and immune regulation genes. The phenotypes of infants with genetic causes of neonatal lung disease may have some features that are difficult to distinguish clinically from more common, reversible causes of lung disease, and from each other. Multigene panels are now available that can allow for a specific diagnosis, providing important information for treatment and prognosis. This review discusses genes in which abnormalities are known to cause neonatal lung disease and their associated phenotypes, and advantages and limitations of genetic testing.

摘要

遗传机制现已被认为是新生儿肺部疾病的罕见病因。可能导致新生儿肺部疾病的基因包括那些编码在表面活性剂功能和代谢中起重要作用的蛋白质的基因、在肺发育中起重要作用的转录因子、参与纤毛组装和功能的蛋白质,以及各种其他结构和免疫调节基因。患有新生儿肺部疾病遗传病因的婴儿的表型可能具有一些临床特征,难以与更常见的、可逆的肺部疾病病因相区分,也难以相互区分。现在有多种基因检测 panel 可供使用,能够实现特定诊断,为治疗和预后提供重要信息。本综述讨论了已知异常会导致新生儿肺部疾病的基因及其相关表型,以及基因检测的优缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94b/8001923/e8cdb7409663/children-08-00216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94b/8001923/e8cdb7409663/children-08-00216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94b/8001923/e8cdb7409663/children-08-00216-g001.jpg

相似文献

1
Genetic Testing for Neonatal Respiratory Disease.新生儿呼吸系统疾病的基因检测
Children (Basel). 2021 Mar 11;8(3):216. doi: 10.3390/children8030216.
2
Inherited disorders of neonatal lung diseases.新生儿肺部疾病的遗传性疾病。
Turk J Pediatr. 2004 Apr-Jun;46(2):105-14.
3
Persistent Respiratory Distress in the Term Neonate: Genetic Surfactant Deficiency Diseases.足月儿持续性呼吸窘迫:遗传性表面活性物质缺乏疾病
Curr Pediatr Rev. 2020;16(1):17-25. doi: 10.2174/1573396315666190723112916.
4
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.新生儿呼吸窘迫综合征早期与延迟选择性表面活性剂治疗
Cochrane Database Syst Rev. 2000(2):CD001456. doi: 10.1002/14651858.CD001456.
5
Surfactant dysfunction.表面活性剂功能障碍。
Paediatr Respir Rev. 2011 Dec;12(4):223-9. doi: 10.1016/j.prrv.2011.01.005. Epub 2011 Mar 5.
6
Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.婴幼儿和儿童遗传性弥漫性肺疾病的超微结构特征:一项队列研究及综述
Ultrastruct Pathol. 2013 Oct;37(5):356-65. doi: 10.3109/01913123.2013.811454.
7
Genetic causes of surfactant protein abnormalities.表面活性剂蛋白异常的遗传原因。
Curr Opin Pediatr. 2019 Jun;31(3):330-339. doi: 10.1097/MOP.0000000000000751.
8
The genetics of neonatal respiratory disease.新生儿呼吸系统疾病的遗传学
Semin Fetal Neonatal Med. 2005 Jun;10(3):271-82. doi: 10.1016/j.siny.2005.02.004. Epub 2005 Apr 7.
9
Genetic influences and neonatal lung disease.遗传因素与新生儿肺部疾病。
Semin Neonatol. 2003 Feb;8(1):19-27. doi: 10.1016/s1084-2756(02)00196-3.
10
Genetic disorders of neonatal respiratory function.新生儿呼吸功能的遗传疾病。
Pediatr Res. 2001 Aug;50(2):157-62. doi: 10.1203/00006450-200108000-00001.

引用本文的文献

1
Development of a Clinical Risk Assessment Score for Respiratory Distress Due to Respiratory Infections in Early Infancy.早期婴儿期呼吸道感染所致呼吸窘迫临床风险评估评分的制定
Children (Basel). 2025 Jun 9;12(6):746. doi: 10.3390/children12060746.
2
Infant lung transplantation: First German experience including two cases of ABO blood group incompatible transplantations.婴儿肺移植:德国首例经验,包括两例ABO血型不相容移植病例。
JHLT Open. 2025 Mar 31;9:100251. doi: 10.1016/j.jhlto.2025.100251. eCollection 2025 Aug.
3
Review of Precision Medicine and Diagnosis of Neonatal Illness.

本文引用的文献

1
Long Non-Coding RNA : Gene Structure, Expression, and Biological Relevance.长非编码 RNA:基因结构、表达及生物学相关性。
Genes (Basel). 2021 Jan 27;12(2):177. doi: 10.3390/genes12020177.
2
An RCT of Rapid Genomic Sequencing among Seriously Ill Infants Results in High Clinical Utility, Changes in Management, and Low Perceived Harm.一项针对重病婴儿的快速基因组测序的 RCT 研究结果显示其具有高度临床实用性,可改变治疗方法,且被认为造成的伤害较低。
Am J Hum Genet. 2020 Nov 5;107(5):942-952. doi: 10.1016/j.ajhg.2020.10.003.
3
Late Diagnosis of Infants with PCD and Neonatal Respiratory Distress.
精准医学与新生儿疾病诊断综述
Diagnostics (Basel). 2025 Feb 16;15(4):478. doi: 10.3390/diagnostics15040478.
4
Value of brain tissue oxygen saturation in neonatal respiratory distress syndrome: a clinical study.脑组织氧饱和度在新生儿呼吸窘迫综合征中的价值:一项临床研究。
Eur J Transl Myol. 2024 Feb 19;34(1):11863. doi: 10.4081/ejtm.2024.11863.
5
Defining and Promoting Pediatric Pulmonary Health: Developing Biomarkers for Pulmonary Health.定义和促进儿科肺部健康:开发肺部健康的生物标志物。
Pediatrics. 2023 Sep 1;152(Suppl 2). doi: 10.1542/peds.2023-062292C.
6
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell.基因治疗在表面活性物质功能障碍性疾病中的应用:以肺泡Ⅱ型上皮细胞为靶点。
Hum Gene Ther. 2022 Oct;33(19-20):1011-1022. doi: 10.1089/hum.2022.130.
7
Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.早产儿先天性免疫缺陷:识别和诊断面临的挑战。
Front Immunol. 2021 Dec 24;12:758373. doi: 10.3389/fimmu.2021.758373. eCollection 2021.
8
Complete lung agenesis caused by complex genomic rearrangements with neo-TAD formation at the SHH locus.复杂基因组重排导致完全性肺发育不全,并在 SHH 基因座形成新的 TAD。
Hum Genet. 2021 Oct;140(10):1459-1469. doi: 10.1007/s00439-021-02344-6. Epub 2021 Aug 26.
原发性纤毛运动障碍(PCD)患儿及新生儿呼吸窘迫的延迟诊断
J Clin Med. 2020 Sep 4;9(9):2871. doi: 10.3390/jcm9092871.
4
Functional assessment and phenotypic heterogeneity of and mutations in interstitial lung diseases and lung cancer.间质性肺疾病和肺癌中 和 突变的功能评估及表型异质性
Eur Respir J. 2020 Dec 24;56(6). doi: 10.1183/13993003.02806-2020. Print 2020 Dec.
5
Is Rapid Exome Sequencing Standard of Care in the Neonatal and Pediatric Intensive Care Units?快速外显子测序是新生儿和儿科重症监护病房的护理标准吗?
J Pediatr. 2020 Nov;226:14-15. doi: 10.1016/j.jpeds.2020.08.006. Epub 2020 Aug 6.
6
Functional Genomics of Variants.变异的功能基因组学。
Am J Respir Cell Mol Biol. 2020 Oct;63(4):436-443. doi: 10.1165/rcmb.2020-0034MA.
7
The past and future of genetics in pulmonary disease: You can teach an old dog new tricks.肺部疾病遗传学的过去与未来:老狗也能学新招。
Pediatr Pulmonol. 2020 Jul;55(7):1789-1793. doi: 10.1002/ppul.24669.
8
A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants.一项在重症婴儿中比较单体和 trio、快速基因组和外显子组测序的分析和诊断性能的随机、对照试验。
Am J Hum Genet. 2019 Oct 3;105(4):719-733. doi: 10.1016/j.ajhg.2019.08.009. Epub 2019 Sep 26.
9
Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders.致命性肺发育障碍的临床、组织病理学和分子诊断学
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1093-1101. doi: 10.1164/rccm.201903-0495TR.
10
Genetic causes of surfactant protein abnormalities.表面活性剂蛋白异常的遗传原因。
Curr Opin Pediatr. 2019 Jun;31(3):330-339. doi: 10.1097/MOP.0000000000000751.